Occupational Benzene Exposure and Lung Cancer Risk: A Pooled Analysis of 14 Case-Control Studies.

benzene lung cancer occupational exposure

Journal

American journal of respiratory and critical care medicine
ISSN: 1535-4970
Titre abrégé: Am J Respir Crit Care Med
Pays: United States
ID NLM: 9421642

Informations de publication

Date de publication:
09 Oct 2023
Historique:
medline: 9 10 2023
pubmed: 9 10 2023
entrez: 9 10 2023
Statut: aheadofprint

Résumé

Benzene has been classified as carcinogenic to humans, but there is limited evidence linking benzene exposure to lung cancer. We aimed to examine the relationship between occupational benzene exposure and lung cancer. Subjects from 14 case-control studies across Europe and Canada were pooled. We used a quantitative job-exposure matrix to estimate benzene exposure. Logistic regression models assessed lung cancer risk across different exposure indices. We adjusted for smoking and five main occupational lung carcinogens and stratified analyses by smoking status and lung cancer subtypes. Analyses included 28048 subjects (12329 cases, 15719 controls). Lung cancer odds ratios ranged from 1.12 (95% CI: 1.03-1.22) to 1.32 (95% CI: 1.18-1.48) ( We found consistent and robust associations between different dimensions of occupational benzene exposure and lung cancer after adjusting for smoking and main occupational lung carcinogens. These associations were observed across different subgroups, including non-smokers. Our findings support the hypothesis that occupational benzene exposure increases the risk of developing lung cancer. Consequently, there is a need to revisit published epidemiological and molecular data on the pulmonary carcinogenicity of benzene.

Identifiants

pubmed: 37812782
doi: 10.1164/rccm.202306-0942OC
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Wenxin Wan (W)

Utrecht University Institute for Risk Assessment Sciences, 225115, Utrecht, Netherlands.

Susan Peters (S)

Utrecht University, 8125, Institute for Risk Assessment Sciences , Utrecht, Netherlands.

Lützen Portengen (L)

Utrecht University, 8125, Institute for Risk Assessment Sciences , Utrecht, Netherlands.

Ann Olsson (A)

International Agency for Research on Cancer, 56140, Lyon, Rhône-Alpes , France.

Joachim Schüz (J)

International Agency for Research on Cancer, 56140, Lyon, Rhône-Alpes , France.

Wolfgang Ahrens (W)

Leibniz Institute for Prevention Research and Epidemiology, 39967, Bremen, Germany.

Miriam Schejbalova (M)

Institute of Hygiene and Epidemiology, First Faculty of Medicine, Charles University, Prague, Czech Republic.

Paolo Boffetta (P)

Stony Brook Cancer Center, Stony Brook University, Stony Brook, New York, United States.
University of Bologna Department of Medical and Surgical Sciences, 198207, Bologna, Emilia-Romagna, Italy.

Thomas Behrens (T)

Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA, Occupational Medical Research & Advice, Bochum, Germany.

Thomas Brüning (T)

Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA, Occupational Medical Research & Advice, Bochum, Germany.

Benjamin Kendzia (B)

Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA, Occupational Medical Research & Advice, Bochum, Germany.

Dario Consonni (D)

Ospedale Maggiore Policlinico, 9339, Milano, Lombardia, Italy.

Paul A Demers (PA)

Ontario Health, 573450, Occupational Cancer Research Centre, Toronto, Ontario, Canada.

Eleonóra Fabiánová (E)

Regional Authority of Public Health, 146974, Banska Bystrica, Slovakia.
Faculty of Health, Catholic University, Ružomberok, Slovakia.

Guillermo Fernández-Tardón (G)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Health Research Institute of Asturias, ISPA and IUOPA, University of Oviedo, Oviedo, Asturias, Spain.

John K Field (JK)

University of Liverpool, Molecular & Clinical Cancer Medicine, Liverpool, United Kingdom of Great Britain and Northern Ireland.

Francesco Forastiere (F)

Department of Epidemiology, ASL Roma E, Rome, Italy.

Lenka Foretova (L)

Masaryk Memorial Cancer Institute, 48275, Brno, Jihomoravský, Czech Republic.

Pascal Guénel (P)

INSERM U1018 Equipe 11, 214050, Villejuif, Île-de-France, France.

Per Gustavsson (P)

Karolinska Institutet Institute of Environmental Medicine, 193414, Stockholm, Sweden.

Karl-Heinz Jöckel (KH)

University of Duisburg-Essen, 27170, Duisburg, Nordrhein-Westfalen, Germany.

Stefan Karrasch (S)

Ludwig-Maximilians-University, Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, Munich, Germany.
Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for Lung Research (DZL), Munich, Germany.
Helmholtz Zentrum München Institute of Epidemiology, 560767, Institute of Epidemiology, Neuherberg, Bayern, Germany.

Maria Teresa Landi (MT)

Department of Health and Human Services, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland, United States.

Jolanta Lissowska (J)

The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland.

Christine Barul (C)

Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, Pointe-à-Pitre, France.

Dana Mates (D)

National Institute of Public Health, Bucharest, Romania; , Bucharest, Romania.

John R McLaughlin (JR)

University of Toronto Dalla Lana School of Public Health, 274071, Toronto, Ontario, Canada.

Franco Merletti (F)

University of Turin Department of Medical Sciences, 145507, Cancer Epidemiology Unit, Torino, Piemonte, Italy.

Enrica Migliore (E)

University of Turin Department of Medical Sciences, 145507, Cancer Epidemiology Unit, Torino, Piemonte, Italy.

Lorenzo Richiardi (L)

University of Turin Department of Medical Sciences, 145507, Cancer Epidemiology Unit, Torino, Piemonte, Italy.

Tamás Pándics (T)

National Public Health Centre, Budapest, Hungary.

Hermann Pohlabeln (H)

Leibniz Institute for Prevention Research and Epidemiology, 39967, Bremen, Germany.

Jack Siemiatycki (J)

University of Montreal Hospital Centre, 25443, Montreal, Quebec, Canada.

Beata Świątkowska (B)

Nofer Institute of Occupational Medicine, 49611, Lodz, Poland.

Heinz-Erich Wichmann (HE)

Helmholtz Zentrum München Institute of Epidemiology, 560767, Institute of Epidemiology, Neuherberg, Bayern, Germany.
Ludwig Maximilians University Munich, 9183, Munchen, Bayern, Germany.

David Zaridze (D)

Russian Cancer Research Centre, Moscow, Russian Federation.

Calvin Ge (C)

Nederlandse Organisatie voor Toegepast Natuurwetenschappelijk Onderzoek, 2859, Utrecht, South Holland, Netherlands.

Kurt Straif (K)

ISGlobal, 310844, Barcelona, Catalunya, Spain.
Boston College, 6019, Chestnut Hill, Massachusetts, United States.

Hans Kromhout (H)

Utrecht University Institute for Risk Assessment Sciences, 225115, Utrecht, Netherlands.

Roel Vermeulen (R)

Utrecht University Institute for Risk Assessment Sciences, 225115, Utrecht, Netherlands; r.c.h.vermeulen@uu.nl.

Classifications MeSH